PPD sales rise as CRO sector stays buoyant

By Kirsty barnes

- Last updated on GMT

Related tags Cent Contract research organization Marketing Generally accepted accounting principles

PPD saw its sales rise 17 per cent in the fourth quarter, fuelled
by its large Development segment.

The US-based contract research organisation (CRO) also reported a 23 per cent rise in operating profit to $58m (€45m) and a pre-tax profit jump of 32 per cent to $62.3m.

These increases are typical of business performances being achieved by other large international CROs as this sector of pharmaceutical outsourcing remains buoyant.

Rival firm Parexel, for example, recently reported that its sales for the three months ending 31 December rose 21 per cent to $180.5m, while also recording a substantial 31 per cent increase in operating income to $13.9m, from $10.6m in the same quarter last year.

Meanwhile, all was not well with PPD in Q4. Despite a revenue increase of 23 per cent to $5.2m, the company's small Discovery Sciences segment continued to remain loss-making, with a loss from operations of $700,000, a slight improvement on the $1.2m loss posted in the comparable 2005 quarter.

Direct spending on the segment was also kept to a minimum by the firm, increasing only 10 per cent.

The company was unavailable for comment.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more